Xi Dong

2.2k total citations
60 papers, 1.7k citations indexed

About

Xi Dong is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Xi Dong has authored 60 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Epidemiology and 14 papers in Immunology. Recurrent topics in Xi Dong's work include Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (8 papers). Xi Dong is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (8 papers). Xi Dong collaborates with scholars based in China, Canada and Hong Kong. Xi Dong's co-authors include Guibo Sun, Qin Ning, Yun Luo, Xiaobo Sun, Xiangbao Meng, Xiaoping Luo, Haojun Zhang, Tingting Zhao, Meihua Yan and Yingli Yu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Xi Dong

59 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi Dong China 26 791 389 242 167 164 60 1.7k
Jibo Han China 23 869 1.1× 191 0.5× 286 1.2× 89 0.5× 93 0.6× 63 1.5k
Yifei Zhong China 23 932 1.2× 221 0.6× 274 1.1× 169 1.0× 164 1.0× 52 2.1k
Shaogui Wang China 28 1.0k 1.3× 875 2.2× 190 0.8× 75 0.4× 220 1.3× 45 2.3k
Dingkun Gui China 24 690 0.9× 279 0.7× 112 0.5× 295 1.8× 165 1.0× 55 1.7k
Yuanyuan Zhang China 28 927 1.2× 203 0.5× 418 1.7× 127 0.8× 153 0.9× 102 2.4k
Zhou‐Yan Bian China 31 1.1k 1.4× 189 0.5× 270 1.1× 146 0.9× 172 1.0× 63 2.2k
Yuan Yuan China 27 853 1.1× 541 1.4× 230 1.0× 119 0.7× 165 1.0× 81 2.0k

Countries citing papers authored by Xi Dong

Since Specialization
Citations

This map shows the geographic impact of Xi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Dong more than expected).

Fields of papers citing papers by Xi Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Dong. The network helps show where Xi Dong may publish in the future.

Co-authorship network of co-authors of Xi Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Dong. A scholar is included among the top collaborators of Xi Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Dong. Xi Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chengjie, Ting Song, Junjie Yu, et al.. (2025). Yucan granules alleviate renal injury in diabetic nephropathy by targeting ECH1, DHRS4, ECI2, and ECHS1. Journal of Ethnopharmacology. 356. 120756–120756.
2.
Luo, Yun, Xi Dong, Shan Lu, et al.. (2021). Gypenoside XVII alleviates early diabetic retinopathy by regulating Müller cell apoptosis and autophagy in db/db mice. European Journal of Pharmacology. 895. 173893–173893. 37 indexed citations
3.
Zhao, Hailing, Haojun Zhang, Tingting Zhao, et al.. (2020). Association between PNPLA2 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in a Chinese Han Population with Type 2 Diabetes. Journal of Diabetes Research. 2020. 1–7. 4 indexed citations
4.
Dong, Xi, Zhu Feng Yue, Shan Wang, et al.. (2020). Bavachinin inhibits cholesterol synthesis enzyme FDFT1 expression via AKT/mTOR/SREBP-2 pathway. International Immunopharmacology. 88. 106865–106865. 31 indexed citations
5.
Zhao, Tingting, Haojun Zhang, Xingbin Yin, et al.. (2020). Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats. Biomedicine & Pharmacotherapy. 129. 110325–110325. 51 indexed citations
6.
Nan, Fengwei, Guibo Sun, Weijie Xie, et al.. (2019). Ginsenoside Rb1 mitigates oxidative stress and apoptosis induced by methylglyoxal in SH-SY5Y cells via the PI3K/Akt pathway. Molecular and Cellular Probes. 48. 101469–101469. 23 indexed citations
7.
Yu, Haijing, Yang Liu, Hongwu Wang, et al.. (2018). Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression. Frontiers in Immunology. 9. 2935–2935. 6 indexed citations
8.
Zhao, Hailing, Xin Li, Tingting Zhao, et al.. (2017). Tangshen formula attenuates diabetic renal injuries by upregulating autophagy via inhibition of PLZF expression. PLoS ONE. 12(2). e0171475–e0171475. 20 indexed citations
9.
Wang, Ming, Xi Dong, & Qin Ning. (2017). Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatology International. 11(2). 171–180. 46 indexed citations
10.
Yang, Liping, Yongli Zhan, Huijie Liu, et al.. (2016). Yi Qi Qing Re Gao-containing serum inhibits lipopolysaccharide-induced rat mesangial cell proliferation by suppressing the Wnt pathway and TGF-β1 expression. Experimental and Therapeutic Medicine. 11(4). 1410–1416. 6 indexed citations
11.
Zhang, Haojun, et al.. (2016). Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice. International Journal of Molecular Medicine. 38(6). 1715–1726. 30 indexed citations
12.
Luo, Yun, Guibo Sun, Xi Dong, et al.. (2015). Isorhamnetin Attenuates Atherosclerosis by Inhibiting Macrophage Apoptosis via PI3K/AKT Activation and HO-1 Induction. PLoS ONE. 10(3). e0120259–e0120259. 88 indexed citations
13.
Meng, Xiangbao, Min Wang, Guibo Sun, et al.. (2014). Attenuation of Aβ25–35-induced parallel autophagic and apoptotic cell death by gypenoside XVII through the estrogen receptor-dependent activation of Nrf2/ARE pathways. Toxicology and Applied Pharmacology. 279(1). 63–75. 82 indexed citations
14.
Zhan, Yongli, Liping Yang, Huijie Liu, et al.. (2014). Yi Qi Qing Re Gao Attenuates Podocyte Injury and Inhibits Vascular Endothelial Growth Factor Overexpression in Puromycin Aminonucleoside Rat Model. Evidence-based Complementary and Alternative Medicine. 2014(1). 375986–375986. 4 indexed citations
15.
Wang, Xiaojing, Weiming Yan, Fengming Chen, et al.. (2012). CD4–CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation. Cellular Immunology. 280(1). 76–84. 5 indexed citations
16.
Han, Meifang, Wei Yan, Yufeng Huang, et al.. (2008). The Nucleocapsid Protein of SARS-CoV Induces Transcription of hfgl2 Prothrombinase Gene Dependent on C/EBP Alpha. The Journal of Biochemistry. 144(1). 51–62. 25 indexed citations
17.
Su, Kai, Fang Chen, Weiming Yan, et al.. (2008). Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-γ. World Journal of Gastroenterology. 14(39). 5980–5980. 46 indexed citations
18.
Han, Meifang, Xi Dong, Weiming Yan, et al.. (2007). Hepatitis B Virus Proteins Induce Activation of hfgl2 Prothrombinase Gene Through c-Ets-2 Transcription Factors. Clinical Immunology. 123. S156–S156. 1 indexed citations
19.
Zhu, Fan, Na Qin, Yue Chen, et al.. (2004). [Hfgl2/fibroleukin expression in liver and peripheral blood mononuclear cells (PBMC) and its correlation with disease severity].. PubMed. 12(7). 385–8. 2 indexed citations
20.
Zhao, Hong, Xi Dong, Xiong Wang, et al.. (2002). Studies on Single-Cell Adhesion Probability between Lymphocytes and Endothelial Cells with Micropipette Technique. Microvascular Research. 63(2). 218–226. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026